Many patients with diabetes take glucose-lowering drugs but still fail to achieve satisfactory blood glucose control, for various reasons.Patients should pay attention to the following points during oral antidiabetic therapy. Patients should consult a doctor before adjusting medications and should not make decisions on their own.Current guidelines recommend starting combination therapy with two or even […]
Category: Diabetes Treatment
11 Common Myths About Insulin
When people hear the word “insulin,” what often comes to mind are large needles and hypoglycemia in people who use insulin.Many view insulin as a difficult, painful, or potentially frightening medical treatment.The key point is: before choosing this life-saving therapy, people with type 2 diabetes must understand the basic facts to make informed decisions.Fox News […]
Updated Meta-Analysis: Effects of Different Weight-Loss Medications on Fat Distribution
As one of the most prevalent health problems worldwide, obesity imposes substantial public health and economic burdens, which have attracted increasing attention from patients, regulatory agencies, and biopharmaceutical companies.Currently, research and development efforts are actively exploring weight‑loss medications targeting different pathways in the pathophysiology of obesity.Although various anti‑obesity or glucose‑lowering agents have been widely used […]
New Insulin Pumps and Hybrid Closed-Loop Systems: Toward “Automated Glycemic Control”
Recently, a review article by the team led by Professors Guo Lixin and Pan Qi from Beijing Hospital was published in the journal Aging Med (Milton), interpreting the Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition). The review focuses on the principles, clinical benefits, and application challenges of relevant […]
Needle-Free Insulin Injection: A New Approach to Reducing Pain and Psychological Resistance
Recently, a review article by the team led by Professors Guo Lixin and Pan Qi from Beijing Hospital was published in the journal Aging Med (Milton), interpreting the Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition). The review focuses on the principles, clinical benefits and application challenges of relevant […]
Smart Insulin Pens: Making Injection Behavior “Visible and Traceable
Recently, a review article by the team led by Professors Guo Lixin and Pan Qi from Beijing Hospital was published in the journal Aging Med (Milton), interpreting the Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly in China (2024 Edition). The review focuses on the principles, clinical benefits, and application challenges of […]
Key Progress in Anti-Inflammatory Therapy for CKM Syndrome
At the 2025 Peking University Diabetes Forum & Coastal Long Bridge Symposium on Metabolic Diseases (Season 1, Quanzhou), Dr. Lin Chu of Peking University People’s Hospital emphasized that anti-inflammatory therapy carries important clinical value. However, it should not be used as an isolated intervention. Instead, it should be deeply integrated with standard treatments such as […]
Why Has Anti-Inflammatory Therapy Become a New Target in the Treatment of CKM?
At the 2025 Peking University Diabetes Forum & Coastal Long Bridge Symposium on Metabolic Diseases (Season 1, Quanzhou), Dr. Lin Chu of Peking University People’s Hospital pointed out that anti-inflammatory therapy has important clinical value, aiming to provide a reference for clinical practice.In 2023, the President of the American Heart Association (AHA) formally proposed the […]
Non-Insulin Therapeutic Agents for T1DM
During the 2025 Peking University Diabetes Forum & Coastal Long Bridge Symposium on Metabolic Diseases,Professor Gu Nan from the Department of Endocrinology, Peking University First Hospital, delivered a report on the current application of non‑insulin agents, providing clinicians with scientifically sound and practically valuable references.
Residual Islet Function Still Exists in Patients with Long-Duration T1DM
During the 2025 Peking University Diabetes Forum and Coastal Long Bridge Symposium on Metabolic Diseases,Professor Gu Nan from the Department of Endocrinology, Peking University First Hospital, delivered a report on the current status and challenges of insulin therapy for type 1 diabetes mellitus (T1DM).Insulin replacement therapy is the core treatment for T1DM, but its clinical […]